Cerence Inc. CRNC
We take great care to ensure that the data presented and summarized in this overview for Cerence Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding CRNC
View all-
Black Rock Inc. New York, NY6.98MShares$26.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.33MShares$20.3 Million0.0% of portfolio
-
Van Berkom & Associates Inc.3.86MShares$14.7 Million1.73% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN3.52MShares$13.4 Million0.02% of portfolio
-
Cooper Creek Partners Management LLC New York, NY2.49MShares$9.49 Million1.49% of portfolio
-
State Street Corp Boston, MA1.81MShares$6.89 Million0.0% of portfolio
-
Paradigm Capital Management Inc1.73MShares$6.61 Million1.32% of portfolio
-
American Capital Management Inc New York, NY1.52MShares$5.78 Million0.77% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.36MShares$5.18 Million0.01% of portfolio
-
Great West Life Assurance CO Winnipeg, A21.12MShares$4.25 Million0.04% of portfolio
Latest Institutional Activity in CRNC
Top Purchases
Top Sells
About CRNC
Cerence Inc. provides AI powered virtual assistants for the mobility/transportation market worldwide. The company offers edge software components; cloud-connected components and related toolkits and applications; and virtual assistant coexistence and professional services. It also provides conversational artificial intelligence-based solutions, including speech recognition, natural language understanding, speech signal enhancement, text-to-speech, and acoustic modeling technology. Cerence Inc. is headquartered in Burlington, Massachusetts.
Insider Transactions at CRNC
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 22
2024
|
Stefan Ortmanns Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,249
-1.0%
|
$15,747
$3.87 P/Share
|
May 07
2024
|
Thomas L Beaudoin |
SELL
Open market or private sale
|
Direct |
5,464
-2.2%
|
$49,176
$9.69 P/Share
|
May 01
2024
|
Thomas L Beaudoin |
SELL
Open market or private sale
|
Direct |
5,000
-1.98%
|
$45,000
$9.03 P/Share
|
Apr 22
2024
|
Stefan Ortmanns Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
10,762
-2.0%
|
$107,620
$10.04 P/Share
|
Apr 01
2024
|
Thomas L Beaudoin |
SELL
Open market or private sale
|
Direct |
5,000
-0.97%
|
$75,000
$15.35 P/Share
|
Mar 22
2024
|
Stefan Ortmanns Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
15,389
-2.79%
|
$215,446
$14.82 P/Share
|
Mar 21
2024
|
Thomas L Beaudoin |
SELL
Open market or private sale
|
Direct |
5,000
-1.9%
|
$70,000
$14.99 P/Share
|
Mar 18
2024
|
Daniel David Tempesta CFO |
BUY
Grant, award, or other acquisition
|
Direct |
307,797
+45.0%
|
$0
$0.01 P/Share
|
Mar 14
2024
|
Stefan Ortmanns Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
21,446
-3.74%
|
$300,244
$14.73 P/Share
|
Feb 15
2024
|
Thomas L Beaudoin |
BUY
Grant, award, or other acquisition
|
Direct |
1,005
+0.38%
|
$13,065
$13.58 P/Share
|
Feb 15
2024
|
Marcy S Klevorn Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,196
+36.57%
|
$0
$0.01 P/Share
|
Feb 15
2024
|
Alfred A Nietzel Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,196
+18.25%
|
$0
$0.01 P/Share
|
Feb 15
2024
|
Kristi Ann Matus Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,196
+18.45%
|
$0
$0.01 P/Share
|
Feb 15
2024
|
Sanjay K Jha Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,196
+16.19%
|
$0
$0.01 P/Share
|
Feb 15
2024
|
Marianne Budnik Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,196
+16.19%
|
$0
$0.01 P/Share
|
Feb 15
2024
|
Douglas Lee Davis Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,196
+30.21%
|
$0
$0.01 P/Share
|
Feb 15
2024
|
Arun Sarin Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,196
+11.85%
|
$0
$0.01 P/Share
|
Jan 12
2024
|
Stefan Ortmanns Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
11,942
-2.04%
|
$226,898
$19.26 P/Share
|
Jan 09
2024
|
Thomas L Beaudoin |
SELL
Open market or private sale
|
Direct |
5,185
-1.94%
|
$93,330
$18.79 P/Share
|
Jan 09
2024
|
Iqbal Arshad EVP, CTO |
SELL
Open market or private sale
|
Direct |
5,188
-2.13%
|
$93,384
$18.79 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 712K shares |
---|
Open market or private sale | 180K shares |
---|